Chronic Myeloid Leukaemia: A Qualitative Study of Patient and Practitioner Experiences of Managing Treatment

Table 2

HCP characteristics.

Study ID	Role	Years in role	Hospital type	Specialism	Clinic type
PR01	CNS1	10 years+	CC^2	Myeloid⁴ ± CML	Specialist CML
PR02	Consultant	10 years+	CC	Myeloid ± CML	Specialist CML
PR03	CNS	10 years+	CC	Myeloid ± CML	Specialist CML
PR04	CNS	10 years+	LH³	Myeloid ± CML	General haematology
PR05	CNS	10 years+	LH	Myeloid ± CML	Specialist CML/general haematology
PR06	Consultant	10 years+	LH	Generalist⁵	General haematology
PR08	CNS	1–5 years	LH	Myeloid ± CML	Specialist CML
PR10	Consultant	10 years+	LH	Myeloid ± CML	General haematology
PR11	Consultant	1–5 years	LH	Myeloid ± CML	General haematology
PR14	CNS	10 years+	CC	Myeloid ± CML	Specialist CML
PR15	Consultant	1–5 years	LH	Generalist	General haematology
PR19	CNS	10 years+	LH	Generalist	General haematology
PR20	Consultant	1–5 years	CC	Myeloid ± CML	Specialist CML

Missing IDs represent invited HCPs who did not participate. ¹CNS-clinical nurse specialist. ²CC-cancer centre; ³LH-local hospital, ⁴Myeloid-manages patients with myeloid malignancies, including CML, and/or a specific interest in caring for CML patients, ⁵Generalist-manages patients with a range of haematological malignancies and disorders.